Ondas Holdings Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K, dated August 28, 2024, reports a material definitive agreement entered into by Ondas Holdings Inc. (ONDS). The filing details a registered direct offering of common stock and warrants to an institutional investor, with the transaction closing on August 30, 2024.
Key Financial Metrics and Transaction Details
- Gross Proceeds: Approximately $4.0 million before deducting placement agent fees and offering expenses.
- Securities Issued: 5,333,334 shares of Common Stock.
- Warrants Issued:
- Series A Warrants: To purchase up to 5,333,334 shares; exercise price $0.8073; exercisable after 6 months; expire in 2.5 years.
- Series B Warrants: To purchase up to 5,333,334 shares; exercise price $0.8073; exercisable after 6 months; expire in 5.5 years.
- Offering Price: $0.75 per share (combined price for one share of Common Stock, one Series A Warrant, and one Series B Warrant).
- Placement Agent Fees: 7.0% of gross proceeds paid to Maxim Group LLC, plus reimbursement of out-of-pocket expenses (legal fees capped at $100,000).
Material Changes and Restrictions
The filing does not provide comparative financial metrics (revenue, profit, cash flow) as this is a transactional report rather than a periodic financial statement. The primary material change is the increase in share count and potential dilution from the issuance of 5,333,334 new shares and 10,666,668 warrants. The Company has agreed to a 90-day lock-up period restricting the issuance of additional Common Stock or Common Stock Equivalents following the closing.
Outlook, Risks, and Contingencies
The Company utilized an existing effective registration statement on Form S-3 (File No. 333-276852) for this offering. The filing notes customary representations, warranties, and indemnification obligations. No specific forward-looking guidance or new risk factors beyond standard transactional risks were disclosed in this specific text.
Key Facts for Investor Verification
- Verify the exact net proceeds after deducting the 7% placement fee and legal expenses.
- Confirm the impact of the 5,333,334 new shares and 10,666,668 warrants on fully diluted share count and earnings per share.
- Review the 90-day lock-up restrictions on future equity issuances.
- Check the exercise terms of the Series A and Series B warrants, specifically the $0.8073 strike price relative to the $0.75 offering price.